1. Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Issue 2 (23rd July 2020) Authors: Lampert, Erika J; Cimino-Mathews, Ashley; Lee, Joo Sang; Nair, Jayakumar; Lee, Min-Jung; Yuno, Akira; An, Daniel; Trepel, Jane B; Ruppin, Eytan; Lee, Jung-Min Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Issue 2 (23rd July 2020) Authors: Lampert, Erika J; Cimino-Mathews, Ashley; Lee, Joo Sang; Nair, Jayakumar; Lee, Min-Jung; Yuno, Akira; An, Daniel; Trepel, Jane B; Ruppin, Eytan; Lee, Jung-Min Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Issue 2 (23rd July 2020) Authors: Lampert, Erika J; Cimino-Mathews, Ashley; Lee, Joo Sang; Nair, Jayakumar; Lee, Min-Jung; Yuno, Akira; An, Daniel; Trepel, Jane B; Ruppin, Eytan; Lee, Jung-Min Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Issue 2 (23rd July 2020) Authors: Lampert, Erika J; Cimino-Mathews, Ashley; Lee, Joo Sang; Nair, Jayakumar; Lee, Min-Jung; Yuno, Akira; An, Daniel; Trepel, Jane B; Ruppin, Eytan; Lee, Jung-Min Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Issue 2 (23rd July 2020) Authors: Lampert, Erika J; Cimino-Mathews, Ashley; Lee, Joo Sang; Nair, Jayakumar; Lee, Min-Jung; Yuno, Akira; An, Daniel; Trepel, Jane B; Ruppin, Eytan; Lee, Jung-Min Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Issue 2 (23rd July 2020) Authors: Lampert, Erika J; Cimino-Mathews, Ashley; Lee, Joo Sang; Nair, Jayakumar; Lee, Min-Jung; Yuno, Akira; An, Daniel; Trepel, Jane B; Ruppin, Eytan; Lee, Jung-Min Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Issue 2 (23rd July 2020) Authors: Lampert, Erika J; Cimino-Mathews, Ashley; Lee, Joo Sang; Nair, Jayakumar; Lee, Min-Jung; Yuno, Akira; An, Daniel; Trepel, Jane B; Ruppin, Eytan; Lee, Jung-Min Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Issue 2 (23rd July 2020) Authors: Lampert, Erika J; Cimino-Mathews, Ashley; Lee, Joo Sang; Nair, Jayakumar; Lee, Min-Jung; Yuno, Akira; An, Daniel; Trepel, Jane B; Ruppin, Eytan; Lee, Jung-Min Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Issue 2 (23rd July 2020) Authors: Lampert, Erika J; Cimino-Mathews, Ashley; Lee, Joo Sang; Nair, Jayakumar; Lee, Min-Jung; Yuno, Akira; An, Daniel; Trepel, Jane B; Ruppin, Eytan; Lee, Jung-Min Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Issue 2 (23rd July 2020) Authors: Lampert, Erika J; Cimino-Mathews, Ashley; Lee, Joo Sang; Nair, Jayakumar; Lee, Min-Jung; Yuno, Akira; An, Daniel; Trepel, Jane B; Ruppin, Eytan; Lee, Jung-Min Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗